Longlong Luo

Taiping Road #27
Taiping, 100850, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Erratum: [Corrigendum] Engineered AXL-ECD-Fc variants that abolish the AXL/Gas6 interaction suppress tumor cell migration.

Erratum: [Corrigendum] Engineered AXL-ECD-Fc variants that abolish the AXL/Gas6 interaction suppress tumor cell migration.

Journal: Oncology letters

Published: June 25, 2026

Pan-filovirus activity of an IGF2-fused monoclonal antibody: Impairment by IGF1R cross-engagement and rescue via IGF2 Y27L mutation.

Pan-filovirus activity of an IGF2-fused monoclonal antibody: Impairment by IGF1R cross-engagement and rescue via IGF2 Y27L mutation.

Journal: Virus research

Published: April 02, 2026

Tailoring virus-inspired nanoparticles for advanced drug and gene delivery.

Tailoring virus-inspired nanoparticles for advanced drug and gene delivery.

Journal: Materials today. Bio

Published: March 11, 2026

A Paradigm Shift in Snakebite Envenoming Therapy: From Conventional Antivenoms to Rationally Designed, Broadly Neutralizing Combination Therapies.

A Paradigm Shift in Snakebite Envenoming Therapy: From Conventional Antivenoms to Rationally Designed, Broadly Neutralizing Combination Therapies.

Journal: ACS pharmacology & translational science

Published: March 05, 2026

Physics-Informed Artificial Intelligence Design of Picomolar Nanobodies Enables Deep Tumor Penetration and High-Contrast Imaging.

Physics-Informed Artificial Intelligence Design of Picomolar Nanobodies Enables Deep Tumor Penetration and High-Contrast Imaging.

Journal: Research (Washington, D.C.)

Published: February 27, 2026

Nanoparticle-free dualmodal lateral flow immunoassay for sensitive detection of aflatoxin B1 based on "four-in-one" multifunctional nanobody.

Nanoparticle-free dualmodal lateral flow immunoassay for sensitive detection of aflatoxin B1 based on "four-in-one" multifunctional nanobody.

Journal: Analytica chimica acta

Published: October 16, 2025

A high-affinity CEA-targeted nanobody for 68Ga PET imaging and 177Lu-based radioisotope therapy: preclinical and first-in-human evaluation.

A high-affinity CEA-targeted nanobody for 68Ga PET imaging and 177Lu-based radioisotope therapy: preclinical and first-in-human evaluation.

Journal: Journal of nanobiotechnology

Published: September 11, 2025

A triple combination strategy for nasopharyngeal carcinoma: Aptamer-guided liposomal chemotherapy, engineered NK cells, and Fc-enhanced PD-L1 antibody therapy.

A triple combination strategy for nasopharyngeal carcinoma: Aptamer-guided liposomal chemotherapy, engineered NK cells, and Fc-enhanced PD-L1 antibody therapy.

Journal: Acta pharmaceutica Sinica. B

Published: August 13, 2025

Comparative evaluation of bispecific antibody formats targeting PD-1 and LAG-3 for dual checkpoint blockade in cancer immunotherapy.

Comparative evaluation of bispecific antibody formats targeting PD-1 and LAG-3 for dual checkpoint blockade in cancer immunotherapy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 28, 2025

Clostridium perfringens alpha toxin drives pathological NETosis via immature neutrophil mobilization and functional reprogramming.

Clostridium perfringens alpha toxin drives pathological NETosis via immature neutrophil mobilization and functional reprogramming.

Journal: Acta pharmaceutica Sinica. B

Published: May 22, 2025

Reshaping antivenom therapy: A triple-synergy strategy featuring broadly neutralizing antibodies and a small-molecule PLA2 inhibitor.

Reshaping antivenom therapy: A triple-synergy strategy featuring broadly neutralizing antibodies and a small-molecule PLA2 inhibitor.

Journal: Acta pharmaceutica Sinica. B

Published: May 13, 2025

Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies.

Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies.

Journal: International journal of molecular sciences

Published: April 03, 2025

Showing 1-12 of 52

Last Updated: 09/26/2026